Principal Financial Group Inc. reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 0.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 597,377 shares of the company’s stock after selling 3,755 shares during the quarter. Principal Financial Group Inc.’s holdings in HCA Healthcare were worth $282,703,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Sumitomo Life Insurance Co. grew its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the last quarter. MJP Associates Inc. ADV grew its stake in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its stake in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after acquiring an additional 21 shares during the last quarter. Anchyra Partners LLC grew its position in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd raised its position in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after purchasing an additional 22 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.
Trending Headlines about HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA said preliminary second-quarter revenue came in above Wall Street expectations, suggesting demand and patient volumes remained solid enough to support top-line growth. Reuters: HCA reports preliminary quarterly revenue above expectations
- Neutral Sentiment: KeyCorp lowered its price target to $475 from $510 but kept an overweight rating, while Wells Fargo trimmed its target to $428 and maintained an equal weight rating, signaling some caution but not a full bearish call. Benzinga: Analyst updates on HCA Healthcare
- Negative Sentiment: HCA reduced its full-year EPS guidance to 28.7 to 30.5, below consensus, indicating margin pressure and a softer profit outlook for the rest of the year.
- Negative Sentiment: Management cited payer mix shifts tied to health insurance exchanges, along with rising uninsured patients and declining surgeries, as factors squeezing quarterly earnings and hurting expectations. WSJ: HCA Healthcare shares drop after quarterly earnings squeezed by payer mix shifts
- Negative Sentiment: Barron’s reported that the stock fell after the company lowered its outlook, reinforcing investor concern that the strong revenue trend may not translate into comparable profit growth. Barrons: HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on HCA Healthcare
HCA Healthcare Trading Down 6.7%
Shares of HCA opened at $364.46 on Wednesday. The firm’s fifty day simple moving average is $395.39 and its two-hundred day simple moving average is $458.95. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The stock has a market capitalization of $80.85 billion, a P/E ratio of 12.53, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.9%. HCA Healthcare’s payout ratio is currently 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
